Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy

Journal of Vascular Surgery

Volumn 49, Issue 4, 2009, Pages 1013-1020

  Beidler, Stephanie K ^a   Douillet, Christelle D ^a   Berndt, Daniel F ^a   Keagy, Blair A ^a   Rich, Preston B ^a   Marston, William A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BIOPSY; CHRONIC VEIN INSUFFICIENCY; CLINICAL ARTICLE; COMPRESSION BANDAGE; COMPRESSION THERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LEG ULCER; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; ULCER HEALING; UPREGULATION;

ADULT; AGED; CHRONIC DISEASE; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; STOCKINGS, COMPRESSION; TIME FACTORS; TREATMENT OUTCOME; VARICOSE ULCER; VENOUS INSUFFICIENCY; WOUND HEALING;

EID: 63049120453     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.11.049     Document Type: Article

References (42)

1. McGuckin M., Waterman R., Brooks J., Cherry G., Porten L., Hurley S., and Kerstein M.D. Validation of venous leg ulcer guidelines in the United States and United Kingdom. Am J Surg 183 (2002) 132-137
2. Franks P.J., and Moffatt C.J. Health related quality of life in patients with venous ulceration: use of the Nottingham health profile. Qual Life Res 10 (2001) 693-700
3. Cullum N., Nelson E.A., Fletcher A.W., and Sheldon T.A. Compression for venous leg ulcers. Cochrane database of systematic reviews (Online) (2001) :CD000265.
4. Kunimoto B.T. Management and prevention of venous leg ulcers: a literature-guided approach. Ostomy/wound manage 47 (2001) 36-42 review 44-9.
5. Nelson E.A., Bell-Syer S.E., and Cullum N.A. Compression for preventing recurrence of venous ulcers. Cochrane database of systematic reviews (Online) (2000) :CD002303.
6. Marston W.A., Carlin R.E., Passman M.A., Farber M.A., and Keagy B.A. Healing rates and cost efficacy of outpatient compression treatment for leg ulcers associated with venous insufficiency. J Vasc Surg 30 (1999) 491-498
7. Erickson C.A., Lanza D.J., Karp D.L., Edwards J.W., Seabrook G.R., Cambria R.A., et al. Healing of venous ulcers in an ambulatory care program: the roles of chronic venous insufficiency and patient compliance. J Vasc Surg 22 (1995) 629-636
8. Mayberry J.C., Moneta G.L., Taylor Jr. L.M., and Porter J.M. Fifteen-year results of ambulatory compression therapy for chronic venous ulcers. Surgery 109 (1991) 575-581
9. Wlaschek M., and Scharffetter-Kochanek K. Oxidative stress in chronic venous leg ulcers. Wound Repair Regen 13 (2005) 452-461
10. Chen W.Y., and Rogers A.A. Recent insights into the causes of chronic leg ulceration in venous diseases and implications on other types of chronic wounds. Wound Repair Regen 15 (2007) 434-449
11. Prabhakar U., Eirikis E., and Davis H.M. Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J Immunol Methods 260 (2002) 207-218
12. Radstake T.R., Roelofs M.F., Jenniskens Y.M., Oppers-Walgreen B., van Riel P.L., Barrera P., et al. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum 50 (2004) 3856-3865
13. Natelson B.H., Weaver S.A., Tseng C.L., and Ottenweller J.E. Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin Diagn Lab Immunol 12 (2005) 52-55
14. Labropoulos N., Tiongson J., Pryor L., Tassiopoulos A.K., Kang S.S., Ashraf Mansour M., and Baker W.H. Definition of venous reflux in lower-extremity veins. J Vasc Surg 38 (2003) 793-798
15. Criado E., Farber M.A., Marston W.A., Daniel P.F., Burnham C.B., and Keagy B.A. The role of air plethysmography in the diagnosis of chronic venous insufficiency. J Vasc Surg 27 (1998) 660-670
16. Gorin D.R., Cordts P.R., LaMorte W.W., and Manzoian J.O. The influence of wound geometry on the measurement of wound healing rates in clinical trials. J Vasc Surg 23 (1996) 524-528
17. Kantor J., and Margolis D.J. A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks. Br J Dermatol 142 (2000) 960-964
18. Phillips T.J., Machado F., Trout R., Porter J., Olin J., and Falanga V. Prognostic indicators in venous ulcers. J Am Acad Dermatol 43 (2000) 627-630
19. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
20. Carson R.T., and Vignali D.A. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 227 (1999) 41-52
21. dupont N.C., Wang K., Wadhwa P.D., Culhane J.F., and Nelson E.L. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 66 (2005) 175-191
22. Ray C.A., Bowsher R.R., Smith W.C., Devanarayan V., Willey M.B., Brandt J.T., and Dean R.A. Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. J Pharm Biomed Anal 36 (2005) 1037-1044
23. Beidler S.K., Douillet C.D., Berndt D.F., Keagy B.A., Rich P.B., and Marston W.A. Multiplexed analysis of matrix metalloproteinases in leg ulcer tissue of patients with chronic venous insufficiency before and after compression therapy. Wound Repair Regen 5 (2008) 642-648
24. Serhan C.N., and Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 6 (2005) 1191-1197
25. Nathan C. Points of control in inflammation. Nature 420 (2002) 846-852
26. Leibovich S.J., and Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 78 (1975) 71-100
27. Greenhalgh D.G., Sprugel K.H., Murray M.J., and Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 136 (1990) 1235-1246
28. Nagaoka T., Kaburagi Y., Hamaguchi Y., Hasegawa M., Takehara K., Steeber D.A., et al. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol 157 (2000) 237-247
29. Hübner G., Brauchle M., Smola H., Madlener M., Fässler R., and Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 8 (1996) 548-556
30. Barone E.J., Yager D.R., Pozez A.L., Olutoye O.O., Crossland M.C., Diegelmann R.F., and Cohen I.K. Interleukin-1alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg 102 (1998) 1023-1027 discussion 1028-9.
31. Trengove N.J., Bielefeldt-Ohmann H., and Stacey M.C. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 8 (2000) 13-25
32. Pappas P.J., You R., Rameshwar P., Gorti R., DeFouw D.O., Phillips C.K., et al. Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta1 gene expression and protein production. J Vasc Surg 30 (1999) 1129-1145
33. Lal B.K., Saito S., Pappas P.J., Padberg Jr. F.T., Cerveira J.J., Hobson II R.W., and Durán W.N. Altered proliferative responses of dermal fibroblasts to TGF-beta1 may contribute to chronic venous stasis ulcer. J Vasc Surg 37 (2003) 1285-1293
34. Banno T., Adachi M., Mukkamala L., and Blumenberg M. Unique keratinocyte-specific effects of interferon-gamma that protect skin from viruses, identified using transcriptional profiling. Antiviral therapy 8 (2003) 541-554
35. Konur A., Schulz U., Eissner G., Andreesen R., and Holler E. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production. Br J Dermatol 152 (2005) 1134-1142
36. Matsuura K., Otsuka F., and Fujisawa H. Effects of interferons on tumour necrosis factor alpha production from human keratinocytes. Cytokine 10 (1998) 500-505
37. Miles R.H., Paxton T.P., Zacheis D., Dries D.J., and Gamelli R.L. Systemic administration of interferon-gamma impairs wound healing. J Surg Res 56 (1994) 288-294
38. Buttmann M., Goebeler M., Toksoy A., Schmid S., Graf W., Berberich-Siebelt F., and Rieckmann P. Subcutaneous interferon-beta injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction. J Neuroimmunol 168 (2005) 175-182
39. Ozden M.G., Erel A., Erdem O., and Oztas M.O. Dermal fibrosis and cutaneous necrosis after recombinant interferon-beta1a injection in a multiple sclerosis patient. J Eur Acad Dermatol Venereol 19 (2005) 112-113
40. Simka M. A potential role of interferon-gamma in the pathogenesis of venous leg ulcers. Med Hypotheses 67 (2006) 639-644
41. Nicklin M.J., Hughes D.E., Barton J.L., Ure J.M., and Duff G.W. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 191 (2000) 303-312
42. Furst D.E. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther 26 (2004) 1960-1975